European Union regulators are hitting the pause button on plans to allow CBD to be sold over the counter and added to foods and dietary supplements.
The EU’s European Food Safety Authority said this week that it doesn’t have enough data to give an opinion on whether CBD is safe for human consumption.
ADVERTISEMENT
“There is insufficient data on the effect of CBD on the liver, gastrointestinal tract, endocrine system, nervous system and on people’s psychological well-being,” the health agency announced.
The agency had been reviewing more than a dozen applications from companies seeking to sell CBD products in EU-member states without a prescription. The delay means those companies have no idea if or when they’ll be able to go to market.
The EU scheduled a June 28 public meeting on CBD and what regulators want to know about it. But officials gave no indication how long it
Read full article on Marijuana Business Daily
